Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-06

Clinical Trial Update: Brain Perfusion & Oxygenation in Parkinson's Disease With NOH [Phase 4]

View source ↗

Summary

Phase 4 trial update on brain perfusion and oxygenation in Parkinson's disease with neurogenic orthostatic hypotension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: William Ondo, MD | Conditions: Parkinson Disease, Neurogenic Orthostatic Hypotension | Phase 4 | Status: COMPLETED